Online Store

USCIPP Telemedicine & Remote Second Opinion Legal Due Diligence Report: Mainland China (Updated September 2021)

PLEASE NOTE THE FOLLOWING:

  • Member organizations may access this report for $1,750. Note that the member discount will be applied after adding the report to your cart, entering billing/contact information, and clicking the "Proceed to Checkout" button. 
     
  • Non-members may access the report for $2,750.
     

In 2019, USCIPP launched an initiative focused on conducting legal due diligence related to the cross-border delivery of international telemedicine and remote second opinions (RSOs). The cost of having local counsel evaluate legal issues related to the delivery of telemedicine and RSOs in a new country/jurisdiction can be very high – sometimes $20,000 or more for a single market. Given the significant fees required to commission this kind of work, USCIPP’s members have encouraged the development of a mechanism that would allow for hospitals to share in the costs of conducting legal assessments regarding the delivery of telemedicine and RSOs in countries/jurisdictions of high interest to the general membership. The goal of collaborating in this fashion is, of course, to enable USCIPP members to complete a large amount of their legal due diligence process for numerous countries/jurisdictions at a substantial discount vs. what it would cost for a single institution to do the work alone.

After polling the broader membership and consulting with experts in law, telemedicine, and international business at several prominent member organizations, USCIPP developed a request for proposal (RFP) to contract for legal services to evaluate cross-border telemedicine and RSO services in a number of different markets chosen by USCIPP members. The RFP was sent to multiple international law firms, and USCIPP’s members were given an opportunity to evaluate the responding firms’ proposals. Hogan Lovells—a large, global law firm with deep experience in this area—was ultimately selected as the organization that submitted the strongest proposal.

USCIPP and its member hospitals developed a standardized matrix that is used to analyze each market’s cross-border telemedicine and RSO legal/regulatory landscape. The final deliverables address legal issues related to the provision of telemedicine and RSOs in these markets. The resultant documents are meant to inform and empower individual institutions’ business and legal teams to develop tailored models of care with appropriate legal documentation.

This report for Mainland China was updated in September 2021 from the first analysis that was originally released in September 2019. This deliverable includes a track changes (vs. the September 2019 report) and a clean version of the file. 

Name

USCIPP Telemedicine & Remote Second Opinion Legal Due Diligence Report: Mainland China (Updated September 2021)

Price

$1,750.00
Members Only
$2,750.00
Non-Members

Qty